ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $301,838 | +29.9% | 14,731 | +26.0% | 0.00% | 0.0% |
| Q2 2023 | $232,340 | +13.5% | 11,693 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $204,686 | -1.9% | 11,949 | +12.1% | 0.00% | 0.0% |
| Q4 2022 | $208,597 | +126.7% | 10,659 | +85.0% | 0.00% | 0.0% |
| Q3 2022 | $92,000 | +16.5% | 5,762 | 0.0% | 0.00% | – |
| Q2 2022 | $79,000 | -13.2% | 5,762 | 0.0% | 0.00% | – |
| Q1 2022 | $91,000 | -37.2% | 5,762 | -13.3% | 0.00% | -100.0% |
| Q4 2021 | $145,000 | +3.6% | 6,645 | +41.4% | 0.00% | 0.0% |
| Q3 2021 | $140,000 | -33.0% | 4,699 | -0.2% | 0.00% | 0.0% |
| Q2 2021 | $209,000 | +1.0% | 4,708 | +0.8% | 0.00% | 0.0% |
| Q1 2021 | $207,000 | -35.5% | 4,671 | -20.2% | 0.00% | -50.0% |
| Q4 2020 | $321,000 | +339.7% | 5,856 | +82.4% | 0.00% | +100.0% |
| Q3 2020 | $73,000 | +9.0% | 3,211 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $67,000 | +191.3% | 3,211 | +95.3% | 0.00% | – |
| Q1 2020 | $23,000 | -37.8% | 1,644 | 0.0% | 0.00% | – |
| Q4 2019 | $37,000 | +94.7% | 1,644 | 0.0% | 0.00% | – |
| Q3 2019 | $19,000 | -24.0% | 1,644 | 0.0% | 0.00% | – |
| Q2 2019 | $25,000 | +66.7% | 1,644 | +98.1% | 0.00% | – |
| Q1 2019 | $15,000 | +25.0% | 830 | 0.0% | 0.00% | – |
| Q4 2018 | $12,000 | -40.0% | 830 | 0.0% | 0.00% | – |
| Q3 2018 | $20,000 | – | 830 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |